DXSP DXS International PLC

Statement re: Further NHS Accreditation

Statement re: Further NHS Accreditation

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Statement Re:  Further NHS Accreditation

DXS International, the digital clinical decision support company, is pleased to announce that on Friday 14 April it received NHS Accreditation for the NHS IM1 Pairing Integration API which provides read and write access to GP patient data throughout the UK.

This important achievement alleviates DXS’ dependency on using the existing commercial integrations provided by the three leading suppliers of primary care patient record systems in the UK. The development will also significantly enhance DXS’ ability to deliver its new ExpertCare Hypertension solution to users such as GPs, nurses and pharmacists throughout the UK, faster, better and more cost effectively.

This 18-month development initiative included building the foundation component of a new cloud based Aios platform which will significantly speed up deployment of various DXS products, automate user workflows and reduce support overhead.

David Immelman, DXS CEO, said “This is an exciting step forward, especially as DXS ExpertCare can help the NHS achieve its new target in England for GP practices to get controlled blood pressure up from 60% to 77% of the 8.5 million hypertensive patients in England which can save thousands of strokes and heart attacks.”

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman      (Chief Executive)

DXS International plc
01252 719800

-systems.co.uk 



Corporate Advisor



 
 
City & Merchant

David Papworth



 
020 7101 7676



 



Corporate Broker



 
 
Hybridan LLP

Claire Louise Noyce



 
020 3764 2341



 

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.



EN
25/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

 PRESS RELEASE

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK ...

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare featured in Innovate UK Research Project DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency.  Funded by DXS and Innovate UK and...

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Research: DXS International plc: Experts to Decide

DXS’s ExpertCare, a digital solution platform, is selected for the Grow Digital Health Midlands Programme. This Programme is a collaboration between Health Innovation East and West Midlands, to provide a platform to encourage digital innovation to address the NHS most pressing challenges. DXS will be exposed to the largest NHS England region, encompassing 11 Integrated Care Systems, and a population of approximately 11.8m people. The programme is designed to help UK technology innovators scale p...

 PRESS RELEASE

Company Update

Company Update DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare selected for prestigious Grow Digital Health Midlands Programme DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to announce that ExpertCare, its digital medicine solution, has been selected for the prestigious Grow Digital Health Midlands Programme. Grow Digital Health Midlands - a new collaboration from Health Innovation East Midlands and Health Innovation West Midlands, has announced its first cohort of nine high-potential digital health companies of which DXS and the ...

 PRESS RELEASE

Statement re Grant of Options and Warrants

Statement re Grant of Options and Warrants DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, announces that it yesterday granted share options to a number of directors, employees, and consultants. Most of these options grants are under an Enterprise Management Incentive (“EMI”) scheme and the remainder under an unapproved share option scheme. All these Share Options are at an exercise pric...

 PRESS RELEASE

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 13 February, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,333.756 Ordinary Shares representing 2.0...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch